Does the lifestyle of patients with psoriasis affect their illness?

[1] Owczarczyk-Saczonek A., Placek W.: Compounds of psoriasis with obesity and overweight. Postępy Hig. Med. Dośw., 2017; 71: 761-772Owczarczyk-Saczonek A. Placek W. Compounds of psoriasis with obesity and overweight Postępy Hig. Med. Dośw 2017 71 761 77210.5604/01.3001.0010.3854Search in Google Scholar

[2] Zięciak T., Rzepa T., Król J., Żaba R.: Stigmatization feelings and depression symptoms in psoriasis patients. Psychiatr. Pol., 2017; 51: 1153-1163Zięciak T. Rzepa T. Król J. Żaba R. Stigmatization feelings and depression symptoms in psoriasis patients Psychiatr. Pol 2017 51 1153 116310.12740/PP/68848Search in Google Scholar

[3] Auker L., Cordingley L., Pye S.R., Griffiths C.E., Young H.S.: What are the barriers to physical activity in patients with chronic plaque psoriasis? Br. J. Dermatol., 2020; 183: 1094-1102Auker L. Cordingley L. Pye S.R. Griffiths C.E. Young H.S. What are the barriers to physical activity in patients with chronic plaque psoriasis? Br. J. Dermatol 2020 183 1094 110210.1111/bjd.18979Search in Google Scholar

[4] Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Cata-pano A.L., Cooney M.T., Corrà U., Cosyns B., Deaton C., et al.: 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). G. Ital. Cardiol., 2017; 18: 547-612Piepoli M.F. Hoes A.W. Agewall S. Albus C. Brotons C. Cata-pano A.L. Cooney M.T. Corrà U. Cosyns B. Deaton C. et al 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) G. Ital. Cardiol 2017 18 547 61210.1007/s12529-016-9583-6Search in Google Scholar

[5] Do Y.K., Lakhani N., Malhotra R., Halstater B., Theng C., Østbye T.: Association between psoriasis and leisure-time physical activity: Findings from the National Health and Nutrition Examination Survey. J. Dermatol., 2015; 42: 148-153Do Y.K. Lakhani N. Malhotra R. Halstater B. Theng C. Østbye T. Association between psoriasis and leisure-time physical activity: Findings from the National Health and Nutrition Examination Survey J. Dermatol 2015 42 148 15310.1111/1346-8138.12721Search in Google Scholar

[6] Ramsay B., O’Reagan M.: A survey of the social and psychological effects of psoriasis. Br. J. Dermatol., 1988; 118: 195-201Ramsay B. O’Reagan M. A survey of the social and psychological effects of psoriasis Br. J. Dermatol 1988 118 195 20110.1111/j.1365-2133.1988.tb01774.xSearch in Google Scholar

[7] Naldi L., Conti A., Cazzaniga S., Patrizi A., Pazzaglia M., Lanzoni A., Veneziano L., Pellacani G., Psoriasis Emilia Romagna Study Group: Diet and physical exercise in psoriasis: A randomized controlled trial. Br. J. Dermatol., 2014; 170: 634-642Naldi L. Conti A. Cazzaniga S. Patrizi A. Pazzaglia M. Lanzoni A. Veneziano L. Pellacani G. Psoriasis Emilia Romagna Study Group: Diet and physical exercise in psoriasis: A randomized controlled trial Br. J. Dermatol 2014 170 634 64210.1111/bjd.12735Search in Google Scholar

[8] Rall L.C., Roubenoff R.: Rheumatoid cachexia: Metabolic abnormalities, mechanisms and interventions. Rheumatology, 2004; 43: 1219-1223Rall L.C. Roubenoff R. Rheumatoid cachexia: Metabolic abnormalities, mechanisms and interventions Rheumatology 2004 43 1219 122310.1093/rheumatology/keh321Search in Google Scholar

[9] Roubenoff R., Roubenoff R.A., Cannon J.G., Kehayias J.J., Zhuang H., Dawson-Hughes B., Dinarello C.A., Rosenberg I.H.: Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J. Clin. Invest., 1994; 93: 2379-2386Roubenoff R. Roubenoff R.A. Cannon J.G. Kehayias J.J. Zhuang H. Dawson-Hughes B. Dinarello C.A. Rosenberg I.H. Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation J. Clin. Invest 1994 93 2379 238610.1172/JCI117244Search in Google Scholar

[10] Walsmith J., Roubenoff R.: Cachexia in rheumatoid arthritis. Int. J. Cardiol., 2002; 85: 89-99Walsmith J. Roubenoff R. Cachexia in rheumatoid arthritis Int. J. Cardiol 2002 85 89 9910.1016/S0167-5273(02)00237-1Search in Google Scholar

[11] Wijnands M., Burgers A.: Stress fracture in long term methotrexate treatment for psoriatic arthritis. Ann. Rheum. Dis., 2001; 60: 736-739Wijnands M. Burgers A. Stress fracture in long term methotrexate treatment for psoriatic arthritis Ann. Rheum. Dis 2001 60 736 73910.1136/ard.60.8.736175380011454635Search in Google Scholar

[12] Zonneveld I.M., Bakker W.K., Dijkstra P.F., Bos J.D., van Soesbergen R.M., Dinant H.J.: Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch. Dermatol., 1996; 132: 184-187Zonneveld I.M. Bakker W.K. Dijkstra P.F. Bos J.D. van Soesbergen R.M. Dinant H.J. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis Arch. Dermatol 1996 132 184 18710.1001/archderm.1996.03890260086013Search in Google Scholar

[13] Simon D., Kleyer A., Bayat S., Tascilar K., Kampylafka E., Meinderink T., Schuster L., Petrov R., Liphardt A.M., Rech J., et al.: Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients. Arthritis Res. Ther., 2019; 21: 162Simon D. Kleyer A. Bayat S. Tascilar K. Kampylafka E. Meinderink T. Schuster L. Petrov R. Liphardt A.M. Rech J. et al Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients Arthritis Res. Ther 2019 21 16210.1136/annrheumdis-2019-eular.7249Search in Google Scholar

[14] Aguiar R., Sequeira J., Meirinhos T., Ambrósio C., Barcelos A.: SARCOSPA-sarcopenia in spondyloarthritis patients. Acta Reumatol. Port., 2014; 39: 322-326Aguiar R. Sequeira J. Meirinhos T. Ambrósio C. Barcelos A. SARCOSPA-sarcopenia in spondyloarthritis patients Acta Reumatol. Port 2014 39 322 326Search in Google Scholar

[15] Krajewska-Włodarczyk M., Owczarczyk-Saczonek A., Placek W.: Changes in body composition and bone mineral density in post-menopausal women with psoriatic arthritis. Reumatologia, 2017; 55: 215-221Krajewska-Włodarczyk M. Owczarczyk-Saczonek A. Placek W. Changes in body composition and bone mineral density in post-menopausal women with psoriatic arthritis Reumatologia 2017 55 215 22110.5114/reum.2017.71627574663129332959Search in Google Scholar

[16] Frediani B., Allegri A., Falsetti P., Storri L., Bisogno S., Baldi F., Filipponi P., Marcolongo R.: Bone mineral density in patients with psoriatic arthritis. J. Rheumatol., 2001; 28: 138-143Frediani B. Allegri A. Falsetti P. Storri L. Bisogno S. Baldi F. Filipponi P. Marcolongo R. Bone mineral density in patients with psoriatic arthritis J. Rheumatol 2001 28 138 143Search in Google Scholar

[17] Borman P., Babaoğlu S., Gur G., Bingol S., Bodur H.: Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin. Rheumatol., 2008; 27: 443-447Borman P. Babaoğlu S. Gur G. Bingol S. Bodur H. Bone mineral density and bone turnover in patients with psoriatic arthritis Clin. Rheumatol 2008 27 443 44710.1007/s10067-007-0725-817876648Search in Google Scholar

[18] Ogdie A., Harter L., Shin D., Baker J., Takeshita J., Choi H.K., Love T.J., Gelfand J.M.: The risk of fracture among patients with psoriatic arthritis and psoriasis: A population-based study. Ann. Rheum. Dis., 2017; 76: 882-885Ogdie A. Harter L. Shin D. Baker J. Takeshita J. Choi H.K. Love T.J. Gelfand J.M. The risk of fracture among patients with psoriatic arthritis and psoriasis: A population-based study Ann. Rheum. Dis 2017 76 882 88510.1136/annrheumdis-2016-210441538486328093419Search in Google Scholar

[19] Dheda K., Cassim B., Patel N., Mody G.M.: A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers. Clin. Rheumatol., 2004; 23: 89Dheda K. Cassim B. Patel N. Mody G.M. A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers Clin. Rheumatol 2004 23 8910.1007/s10067-003-0818-y14749995Search in Google Scholar

[20] Häkkinen A., Sokka T., Kotaniemi A., Kautiainen H., Jappinen I., Laitinen L., Hannonen P.: Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density. J. Rheumatol., 1999; 26: 1257-1263Häkkinen A. Sokka T. Kotaniemi A. Kautiainen H. Jappinen I. Laitinen L. Hannonen P. Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density J. Rheumatol 1999 26 1257 1263Search in Google Scholar

[21] Komatireddy G.R., Leitch R.W., Cella K., Browning G., Minor M.: Efficacy of low load resistive muscle training in patients with rheumatoid arthritis functional class II and III. J. Rheumatol., 1997; 24: 1531-1539Komatireddy G.R. Leitch R.W. Cella K. Browning G. Minor M. Efficacy of low load resistive muscle training in patients with rheumatoid arthritis functional class II and III J. Rheumatol 1997 24 1531 1539Search in Google Scholar

[22] Farkas A., Kemény L.: Alcohol, liver, systemic inflammation and skin: A focus on patients with psoriasis. Skin Pharmacol. Physiol., 2013; 26: 119-126Farkas A. Kemény L. Alcohol, liver, systemic inflammation and skin: A focus on patients with psoriasis Skin Pharmacol. Physiol 2013 26 119 12610.1159/00034886523549156Search in Google Scholar

[23] Kazakevich N., Moody M.N., Landau J.M., Goldberg L.H.: Alcohol and skin disorders: With a focus on psoriasis. Skin Therapy Lett., 2011; 16: 5-6Kazakevich N. Moody M.N. Landau J.M. Goldberg L.H. Alcohol and skin disorders: With a focus on psoriasis Skin Therapy Lett 2011 16 5 6Search in Google Scholar

[24] Al-Jefri K., Newbury-Birch D., Muirhead C.R., Gilvarry E., Araújo-Soares V., Reynolds N.J., Kaner E., Hampton P.J.: High prevalence of alcohol use disorders in patients with inflammatory skin diseases. Br. J. Dermatol., 2017; 177: 837-844Al-Jefri K. Newbury-Birch D. Muirhead C.R. Gilvarry E. Araújo-Soares V. Reynolds N.J. Kaner E. Hampton P.J. High prevalence of alcohol use disorders in patients with inflammatory skin diseases Br. J. Dermatol 2017 177 837 84410.1111/bjd.1549728346655Search in Google Scholar

[25] Kirby B., Richards H.L., Mason D.L., Fortune D.G., Main C.J., Griffiths C.E.: Alcohol consumption and psychological distress in patients with psoriasis. Br. J. Dermatol., 2008; 158: 138-140Kirby B. Richards H.L. Mason D.L. Fortune D.G. Main C.J. Griffiths C.E. Alcohol consumption and psychological distress in patients with psoriasis Br. J. Dermatol 2008 158 138 14010.1111/j.1365-2133.2007.08299.x17999698Search in Google Scholar

[26] McAleer M.A., Mason D.L., Cunningham S., O’Shea S.J., McCormick P.A., Stone C., Collins P., Rogers S., Kirby B.: Alcohol misuse in patients with psoriasis: Identification and relationship to disease severity and psychological distress. Br. J. Dermatol., 2011; 164: 1256-1261McAleer M.A. Mason D.L. Cunningham S. O’Shea S.J. McCormick P.A. Stone C. Collins P. Rogers S. Kirby B. Alcohol misuse in patients with psoriasis: Identification and relationship to disease severity and psychological distress Br. J. Dermatol 2011 164 1256 126110.1111/j.1365-2133.2011.10345.x21457207Search in Google Scholar

[27] Farkas Á., Kemény L.: Psoriasis and alcohol: Is cutaneous ethanol one of the missing links? Br. J. Dermatol., 2010; 162: 711-716Farkas Á. Kemény L. Psoriasis and alcohol: Is cutaneous ethanol one of the missing links? Br. J. Dermatol 2010 162 711 71610.1111/j.1365-2133.2009.09595.x19922527Search in Google Scholar

[28] Adamzik K., McAleer M.A., Kirby B.: Alcohol and psoriasis: Sobering thoughts. Clin. Exp. Dermatol., 2013; 38: 819-822Adamzik K. McAleer M.A. Kirby B. Alcohol and psoriasis: Sobering thoughts Clin. Exp. Dermatol 2013 38 819 82210.1111/ced.1201324252076Search in Google Scholar

[29] Harvima I.T., Nilsson G., Suttle M.M., Naukkarinen A.: Is there a role for mast cells in psoriasis? Arch. Dermatol. Res., 2008; 300: 461-478Harvima I.T. Nilsson G. Suttle M.M. Naukkarinen A. Is there a role for mast cells in psoriasis? Arch. Dermatol. Res 2008 300 461 47810.1007/s00403-008-0874-x18719932Search in Google Scholar

[30] Mendes L.O., Amorim J.P.A., Teixeira G.R., Chuffa L.G., Fioruci B.A., Pimentel T.A., de Mello W. Jr, Padovani C.R., Pereira S., Martinez M., et al.: Mast cells and ethanol consumption: Interactions in the prostate, epididymis and testis of UChB rats. Am. J. Reprod. Immunol., 2011; 66: 170-178Mendes L.O. Amorim J.P.A. Teixeira G.R. Chuffa L.G. Fioruci B.A. Pimentel T.A. de Mello W. Jr Padovani C.R. Pereira S. Martinez M. et al Mast cells and ethanol consumption: Interactions in the prostate, epididymis and testis of UChB rats Am. J. Reprod. Immunol 2011 66 170 17810.1111/j.1600-0897.2010.00958.x21241399Search in Google Scholar

[31] Svanström C., Lonne-Rahm S.B., Nordlind K.: Psoriasis and alcohol. Psoriasis Targets Ther., 2019; 9: 75-79Svanström C. Lonne-Rahm S.B. Nordlind K. Psoriasis and alcohol Psoriasis Targets Ther 2019 9 75 7910.2147/PTT.S164104670903031687362Search in Google Scholar

[32] Gupta A.K., Pandey S.S., Pandey B.L.: Effectiveness of conventional drug therapy of plaque psoriasis in the context of consensus guidelines: A prospective observational study in 150 patients. Ann. Dermatol., 2013; 25: 156-162Gupta A.K. Pandey S.S. Pandey B.L. Effectiveness of conventional drug therapy of plaque psoriasis in the context of consensus guidelines: A prospective observational study in 150 patients Ann. Dermatol 2013 25 156 16210.5021/ad.2013.25.2.156366290723717005Search in Google Scholar

[33] Poikolainen K., Reunala T., Karvonen J., Lauharanta J., Kärkkäinen P.: Alcohol intake: A risk factor for psoriasis in young and middle-aged men?. Br. Med. J., 1990; 300: 780-783Poikolainen K. Reunala T. Karvonen J. Lauharanta J. Kärkkäinen P. Alcohol intake: A risk factor for psoriasis in young and middle-aged men? Br. Med. J 1990 300 780 78310.1136/bmj.300.6727.78016625651969757Search in Google Scholar

[34] Qureshi A.A., Dominguez P.L., Choi H.K., Han J., Curhan G.: Alcohol intake and risk of incident psoriasis in US women: A prospective study. Arch. Dermatol., 2010; 146: 1364-1369Qureshi A.A. Dominguez P.L. Choi H.K. Han J. Curhan G. Alcohol intake and risk of incident psoriasis in US women: A prospective study Arch. Dermatol 2010 146 1364 136910.1001/archdermatol.2010.204301737620713772Search in Google Scholar

[35] Cassano N., Vestita M., Apruzzi D., Vena G.A.: Alcohol, psoriasis, liver disease, and anti-psoriasis drugs. Int. J. Dermatol., 2011; 50: 1323-1331Cassano N. Vestita M. Apruzzi D. Vena G.A. Alcohol, psoriasis, liver disease, and anti-psoriasis drugs Int. J. Dermatol 2011 50 1323 133110.1111/j.1365-4632.2011.05100.x22004481Search in Google Scholar

[36] Higgins E.: The skin and alcohol. In: Comprehensive Handbook of Alcohol Related Pathology, eds.: V.R. Preedy, R.R. Watson. Elsevier Academic Press, Cambridge (MA) 2004, 599-605Higgins E. The skin and alcohol. In: Comprehensive Handbook of Alcohol Related Pathology, eds.: V.R. Preedy, R.R. Watson Elsevier Academic Press Cambridge (MA) 2004 599 60510.1016/B978-012564370-2/50050-7Search in Google Scholar

[37] Higgins E.M., du Vivier A.W.: Cutaneous disease and alcohol misuse. Br. Med. Bull., 1994; 50: 85-98Higgins E.M. du Vivier A.W. Cutaneous disease and alcohol misuse Br. Med. Bull 1994 50 85 9810.1093/oxfordjournals.bmb.a0728877908595Search in Google Scholar

[38] Parisi R., Webb R.T., Carr M.J., Moriarty K.J., Kleyn C.E., Griffiths C.E., Ashcroft D.M.: Alcohol-related mortality in patients with psoriasis a population-based cohort study. JAMA Dermatol., 2017; 153: 1256-1262Parisi R. Webb R.T. Carr M.J. Moriarty K.J. Kleyn C.E. Griffiths C.E. Ashcroft D.M. Alcohol-related mortality in patients with psoriasis a population-based cohort study JAMA Dermatol 2017 153 1256 126210.1001/jamadermatol.2017.3225581744528914955Search in Google Scholar

[39] Wu S., Cho E., Li W.Q., Han J., Qureshi A.A.: Alcohol intake and risk of incident psoriatic arthritis in women. J. Rheumatol., 2015; 42: 835-840Wu S. Cho E. Li W.Q. Han J. Qureshi A.A. Alcohol intake and risk of incident psoriatic arthritis in women J. Rheumatol 2015 42 835 84010.3899/jrheum.140808460006625834201Search in Google Scholar

[40] Thorslund K., Svensson T., Nordlind K., Ekbom A., Fored C.M.: Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: A population-based cohort study. J. Intern. Med., 2013; 274: 281287Thorslund K. Svensson T. Nordlind K. Ekbom A. Fored C.M. Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: A population-based cohort study J. Intern. Med 2013 274 28128710.1111/joim.1209323711088Search in Google Scholar

[41] Rodgman A., Perfetti T.A.: The Chemical Components of Tobacco and Tobacco Smoke. Second Edition. CRC Press, Boca Raton 2013Rodgman A. Perfetti T.A. The Chemical Components of Tobacco and Tobacco Smoke. Second Edition CRC Press Boca Raton 2013Search in Google Scholar

[42] Morris P.B., Ference B.A., Jahangir E., Feldman D.N., Ryan J.J., Bahrami H., El-Chami M.F., Bhakta S., Winchester D.E., Al-Mallah M.H., et al.: Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: Clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American College of Cardiology. J. Am. Coll. Cardiol., 2015; 66: 1378-1391Morris P.B. Ference B.A. Jahangir E. Feldman D.N. Ryan J.J. Bahrami H. El-Chami M.F. Bhakta S. Winchester D.E. Al-Mallah M.H. et al Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: Clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American College of Cardiology J. Am. Coll. Cardiol 2015 66 1378 139110.1016/j.jacc.2015.07.03726383726Search in Google Scholar

[43] Sopori M.: Effects of cigarette smoke on the immune system. Nat. Rev. Immunol., 2002; 2: 372-377Sopori M. Effects of cigarette smoke on the immune system Nat. Rev. Immunol 2002 2 372 37710.1038/nri80312033743Search in Google Scholar

[44] Armstrong A.W., Armstrong E.J., Fuller E.N., Sockolov M.E., Voyles S.V.: Smoking and pathogenesis of psoriasis: A review of oxidative, inflammatory and genetic mechanisms. Br. J. Dermatol., 2011; 165: 1162-1168Armstrong A.W. Armstrong E.J. Fuller E.N. Sockolov M.E. Voyles S.V. Smoking and pathogenesis of psoriasis: A review of oxidative, inflammatory and genetic mechanisms Br. J. Dermatol 2011 165 1162 116810.1111/j.1365-2133.2011.10526.x21777217Search in Google Scholar

[45] Yanagita M., Kobayashi R., Kojima Y., Mori K., Murakami S.: Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-γ upregulation. Cell. Immunol., 2012; 274: 26-33Yanagita M. Kobayashi R. Kojima Y. Mori K. Murakami S. Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-γ upregulation Cell. Immunol 2012 274 26 3310.1016/j.cellimm.2012.02.00722425227Search in Google Scholar

[46] Baba N., Rubio M., Kenins L., Regairaz C., Woisetschlager M., Carballido J.M., Sarfati M.: The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4⁺ Th cells to promote the development of IL-22-secreting Th cells. Hum. Immunol., 2012; 73: 795-800Baba N. Rubio M. Kenins L. Regairaz C. Woisetschlager M. Carballido J.M. Sarfati M. The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4⁺ Th cells to promote the development of IL-22-secreting Th cells Hum. Immunol 2012 73 795 80010.1016/j.humimm.2012.05.00222609446Search in Google Scholar

[47] Jin Y., Yang S., Zhang F., Kong Y., Xiao F., Hou Y., Fan X., Zhang X.: Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: A hospital-based case-control study in China. J. Eur. Acad. Dermatol. Venereol., 2009; 23: 132-137Jin Y. Yang S. Zhang F. Kong Y. Xiao F. Hou Y. Fan X. Zhang X. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: A hospital-based case-control study in China J. Eur. Acad. Dermatol. Venereol 2009 23 132 13710.1111/j.1468-3083.2008.02951.x18702622Search in Google Scholar

[48] Sałata-Nowak J., Flisiak I., Chodynicka B.: Wpływ dymu tytoniowego na skórȩ. Przegl. Dermatol., 2010; 97: 342-348Sałata-Nowak J. Flisiak I. Chodynicka B. Wpływ dymu tytoniowego na skórȩ Przegl. Dermatol 2010 97 342 348Search in Google Scholar

[49] Mills C.M., Srivastava E.D., Harvey I.M., Swift G.L., Newcombe R.G., Holt P.J., Rhodes J.: Smoking habits in psoriasis: A case control study. Br. J. Dermatol., 1992; 127: 18-21Mills C.M. Srivastava E.D. Harvey I.M. Swift G.L. Newcombe R.G. Holt P.J. Rhodes J. Smoking habits in psoriasis: A case control study Br. J. Dermatol 1992 127 18 2110.1111/j.1365-2133.1992.tb14818.x1637689Search in Google Scholar

[50] Naldi L., Tognoni G., Cainelli T.: Analytic epidemiology in psoriasis. J. Invest. Dermatol., 1994; 102: 19S-23SNaldi L. Tognoni G. Cainelli T. Analytic epidemiology in psoriasis J. Invest. Dermatol 1994 102 19S 23 S10.1111/1523-1747.ep123860858006428Search in Google Scholar

[51] Lee Y.H., Song G.G.: Association between circulating 25-hydroxyvitamin D levels and psoriasis, and correlation with disease severity: A meta-analysis. Clin. Exp. Dermatol., 2018; 43: 529-535Lee Y.H. Song G.G. Association between circulating 25-hydroxyvitamin D levels and psoriasis, and correlation with disease severity: A meta-analysis Clin. Exp. Dermatol 2018 43 529 53510.1111/ced.1338129341195Search in Google Scholar

[52] Armstrong A.W., Harskamp C.T., Dhillon J.S., Armstrong E.J.: Psoriasis and smoking: A systematic review and meta-analysis. Br. J. Dermatol., 2014; 170: 304-314Armstrong A.W. Harskamp C.T. Dhillon J.S. Armstrong E.J. Psoriasis and smoking: A systematic review and meta-analysis Br. J. Dermatol 2014 170 304 31410.1111/bjd.1267024117435Search in Google Scholar

[53] Herron M.D., Hinckley M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P., Krueger G.G.: Impact of obesity and smoking on psoriasis presentation and management. Arch. Dermatol., 2005; 141: 1527-1534Herron M.D. Hinckley M. Hoffman M.S. Papenfuss J. Hansen C.B. Callis K.P. Krueger G.G. Impact of obesity and smoking on psoriasis presentation and management Arch. Dermatol 2005 141 1527 153410.1001/archderm.141.12.152716365253Search in Google Scholar

[54] Gisondi P., Tessari G., Conti A., Piaserico S., Schianchi S., Peserico A., Giannetti A., Girolomoni G.: Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study. Br. J. Dermatol., 2007; 157: 68-73Gisondi P. Tessari G. Conti A. Piaserico S. Schianchi S. Peserico A. Giannetti A. Girolomoni G. Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study Br. J. Dermatol 2007 157 68 7310.1111/j.1365-2133.2007.07986.x17553036Search in Google Scholar

[55] Altunay I., Doner N., Mercan S., Demirci G.T.: Stress coping mechanisms in smoking psoriatics. Dermatol. Sin., 2013; 31: 130133Altunay I. Doner N. Mercan S. Demirci G.T. Stress coping mechanisms in smoking psoriatics Dermatol. Sin 2013 31 13013310.1016/j.dsi.2013.02.001Search in Google Scholar

[56] Fortes C., Mastroeni S., Leffondré K., Sampogna F., Melchi F., Mazzotti E., Pasquini P., Abeni D.: Relationship between smoking and the clinical severity of psoriasis. Arch. Dermatol., 2005; 141: 1580-1584Fortes C. Mastroeni S. Leffondré K. Sampogna F. Melchi F. Mazzotti E. Pasquini P. Abeni D. Relationship between smoking and the clinical severity of psoriasis Arch. Dermatol 2005 141 1580 158410.1001/archderm.141.12.158016365261Search in Google Scholar

[57] Naldi L.: Psoriasis and smoking: Links and risks. Psoriasis, 2016; 6: 65-71Naldi L. Psoriasis and smoking: Links and risks Psoriasis 2016 6 65 7110.2147/PTT.S85189568312929387595Search in Google Scholar

[58] Eriksson M.O., Hagforsen E., Lundin I.P., Michaëlsson G.: Palmoplantar pustulosis: A clinical and immunohistological study. Br. J. Dermatol., 1998; 138: 390-398Eriksson M.O. Hagforsen E. Lundin I.P. Michaëlsson G. Palmoplantar pustulosis: A clinical and immunohistological study Br. J. Dermatol 1998 138 390 39810.1046/j.1365-2133.1998.02113.x9580788Search in Google Scholar

[59] Michaëlsson G., Gustafsson K., Hagforsen E.: The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J. Am. Acad. Dermatol., 2006; 54: 737-738Michaëlsson G. Gustafsson K. Hagforsen E. The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking J. Am. Acad. Dermatol 2006 54 737 73810.1016/j.jaad.2005.07.02416546609Search in Google Scholar

[60] Setty A.R., Curhan G., Choi H.K.: Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am. J. Med., 2007; 120: 953-959Setty A.R. Curhan G. Choi H.K. Smoking and the risk of psoriasis in women: Nurses’ Health Study II Am. J. Med 2007 120 953 95910.1016/j.amjmed.2007.06.020269635117976422Search in Google Scholar

[61] Li W., Han J., Qureshi A.A.: Smoking and risk of incident psoriatic arthritis in US women. Ann. Rheum. Dis., 2012; 71: 804-808Li W. Han J. Qureshi A.A. Smoking and risk of incident psoriatic arthritis in US women Ann. Rheum. Dis 2012 71 804 80810.1136/annrheumdis-2011-200416417988722067198Search in Google Scholar

[62] Nguyen U.D., Zhang Y., Lu N., Louie-Gao Q., Niu J., Ogdie A., Gelfand J.M., LaValley M.P., Dubreuil M., Sparks J.A., et al.: Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: A population-based study. Ann. Rheum. Dis., 2018; 77: 119-123Nguyen U.D. Zhang Y. Lu N. Louie-Gao Q. Niu J. Ogdie A. Gelfand J.M. LaValley M.P. Dubreuil M. Sparks J.A. et al Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: A population-based study Ann. Rheum. Dis 2018 77 119 12310.1136/annrheumdis-2017-211625597875929102956Search in Google Scholar

[63] Tillett W., Jadon D., Shaddick G., Cavill C., Korendowych E., de Vries C.S., McHugh N.: Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann. Rheum. Dis., 2013; 72: 1358-1361Tillett W. Jadon D. Shaddick G. Cavill C. Korendowych E. de Vries C.S. McHugh N. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis Ann. Rheum. Dis 2013 72 1358 136110.1136/annrheumdis-2012-20260823291384Search in Google Scholar

[64] Thorneloe R.J., Bundy C., Griffiths C.E.M., Ashcroft D.M., Cordingley L.: Adherence to medication in patients with psoriasis: A systematic literature review. Br. J. Dermatol., 2013; 168: 20-31Thorneloe R.J. Bundy C. Griffiths C.E.M. Ashcroft D.M. Cordingley L. Adherence to medication in patients with psoriasis: A systematic literature review Br. J. Dermatol 2013 168 20 3110.1111/bjd.1203922963128Search in Google Scholar

[65] Kinahan C.E., Mazloom S., Fernandez A.P.: Impact of smoking on response to systemic treatment in patients with psoriasis: A retrospective case-control study. Br. J. Dermatol., 2015; 172: 428436Kinahan C.E. Mazloom S. Fernandez A.P. Impact of smoking on response to systemic treatment in patients with psoriasis: A retrospective case-control study Br. J. Dermatol 2015 172 42843610.1111/bjd.1335925142556Search in Google Scholar

[66] Di Lernia V., Ricci C., Lallas A., Ficarelli E.: Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: A retrospective study. J. Dermatolog. Treat., 2014; 25: 73-74Di Lernia V. Ricci C. Lallas A. Ficarelli E. Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: A retrospective study J. Dermatolog. Treat 2014 25 73 7410.3109/09546634.2013.80018423621374Search in Google Scholar

[67] Højgaard P., Glintborg B., Hetland M.L., Hansen T.H., Lage-Hansen P.R., Petersen M.H., Holland-Fischer M., Nilsson C., Loft A.G., Andersen B.N., et al.: Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: Results from the DANBIO registry. Ann. Rheum. Dis., 2015; 74: 2130-2136Højgaard P. Glintborg B. Hetland M.L. Hansen T.H. Lage-Hansen P.R. Petersen M.H. Holland-Fischer M. Nilsson C. Loft A.G. Andersen B.N. et al Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: Results from the DANBIO registry Ann. Rheum. Dis 2015 74 2130 213610.1136/annrheumdis-2014-20538925063827Search in Google Scholar

[68] Owczarczyk-Saczonek A.B., Owczarczyk J., Krajewska-Włodarczyk M., Wojtkiewicz J., Placek W.. Are psoriasis and psoriatic arthritis associated with chronic obstructive pulmonary disease? Przegl. Dermatol., 2019; 106: 185-197Owczarczyk-Saczonek A.B. Owczarczyk J. Krajewska-Włodarczyk M. Wojtkiewicz J. Placek W. Are psoriasis and psoriatic arthritis associated with chronic obstructive pulmonary disease? Przegl. Dermatol 2019 106 185 19710.5114/dr.2019.85576Search in Google Scholar

[69] Hrehorów E., Salomon J., Matusiak L., Reich A., Szepietowski J.C.: Patients with psoriasis feel stigmatized. Acta Derm. Venereol., 2012; 92: 67-72Hrehorów E. Salomon J. Matusiak L. Reich A. Szepietowski J.C. Patients with psoriasis feel stigmatized Acta Derm. Venereol 2012 92 67 7210.2340/00015555-119321879243Search in Google Scholar

[70] Shelton R.C., Miller A.H.: Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression. Prog. Neurobiol., 2010; 91: 275-299Shelton R.C. Miller A.H. Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression Prog. Neurobiol 2010 91 275 29910.1016/j.pneurobio.2010.04.004292981020417247Search in Google Scholar

[71] Ogłodek E., Marek L., Araszkiewicz A., Placek W., Moś D.: Aleksytymia u pacjenta choruja̧ cego na łuszczycȩ i depresjȩ. Przegl. Dermatol., 2009; 96: 363-366Ogłodek E. Marek L. Araszkiewicz A. Placek W. Moś D. Aleksytymia u pacjenta choruja̧ cego na łuszczycȩ i depresjȩ Przegl. Dermatol 2009 96 363 366Search in Google Scholar

[72] Chen Y., Xin T., Cheng A.S.: Evaluating the effectiveness of psychological and/or educational interventions in psoriasis: A narrative review. J. Dermatol., 2014; 41: 775-778Chen Y. Xin T. Cheng A.S. Evaluating the effectiveness of psychological and/or educational interventions in psoriasis: A narrative review J. Dermatol 2014 41 775 77810.1111/1346-8138.1258325109476Search in Google Scholar

[73] Kurd S.K., Troxel A.B., Crits-Christoph P., Gelfand J.M.: The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study. Arch. Dermatol., 2010; 146: 891895Kurd S.K. Troxel A.B. Crits-Christoph P. Gelfand J.M. The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study Arch. Dermatol 2010 146 89189510.1001/archdermatol.2010.186Search in Google Scholar

[74] Wojtyna E., Łakuta P., Marcinkiewicz K., Bergler-Czop B., Brzezińska-Wcisło L.: Gender, body image and social support: Biopsychosocial determinants of depression among patients with psoriasis. Acta Derm. Venereol., 2017; 97: 91-97Wojtyna E. Łakuta P. Marcinkiewicz K. Bergler-Czop B. Brzezińska-Wcisło L. Gender, body image and social support: Biopsychosocial determinants of depression among patients with psoriasis Acta Derm. Venereol 2017 97 91 9710.2340/00015555-248327304233Search in Google Scholar

[75] Singh S., Taylor C., Kornmehl H., Armstrong A.W.: Psoriasis and suicidality: A systematic review and meta-analysis. J. Am. Acad. Dermatol., 2017; 77: 425-440.2Singh S. Taylor C. Kornmehl H. Armstrong A.W. Psoriasis and suicidality: A systematic review and meta-analysis J. Am. Acad. Dermatol 2017 77 425 440210.1016/j.jaad.2017.05.01928807109Search in Google Scholar

[76] Takahashi H., Tsuji H., Honma M., Shibaki H., Nakamura S., Hashimoto Y., Takahashi M., Koike K., Takei A., Ishida-Yamamoto A., Iizuka H.: Japanese patients with psoriasis and atopic dermatitis show distinct personality profiles. J. Dermatol., 2013; 40: 370373Takahashi H. Tsuji H. Honma M. Shibaki H. Nakamura S. Hashimoto Y. Takahashi M. Koike K. Takei A. Ishida-Yamamoto A. Iizuka H. Japanese patients with psoriasis and atopic dermatitis show distinct personality profiles J. Dermatol 2013 40 37037310.1111/1346-8138.1208723414205Search in Google Scholar

[77] Randa H., Lomholt J.J., Skov L., Zachariae R.: Health-related quality of life in adolescents with psoriasis: An interview-based study. Br. J. Dermatol., 2018; 178: 1404-1411Randa H. Lomholt J.J. Skov L. Zachariae R. Health-related quality of life in adolescents with psoriasis: An interview-based study Br. J. Dermatol 2018 178 1404 141110.1111/bjd.1632629315491Search in Google Scholar

[78] Łakuta P., Przybyła-Basista H.: Toward a better understanding of social anxiety and depression in psoriasis patients: The role of determinants, mediators, and moderators. J. Psychosom. Res., 2017; 94: 32-38Łakuta P. Przybyła-Basista H. Toward a better understanding of social anxiety and depression in psoriasis patients: The role of determinants, mediators, and moderators J. Psychosom. Res 2017 94 32 3810.1016/j.jpsychores.2017.01.00728183400Search in Google Scholar

[79] Lim D.S., Bewley A., Oon H.H.: Psychological profile of patients with psoriasis. Ann. Acad. Med. Singap., 2018; 47: 516-522Lim D.S. Bewley A. Oon H.H. Psychological profile of patients with psoriasis Ann. Acad. Med. Singap 2018 47 516 52210.47102/annals-acadmedsg.V47N12p516Search in Google Scholar

[80] Krajewska-Włodarczyk M., Owczarczyk-Saczonek A., Placek W.: Sleep disorders in patients with psoriatic arthritis and psoriasis. Reumatologia, 2018; 56: 301-306Krajewska-Włodarczyk M. Owczarczyk-Saczonek A. Placek W. Sleep disorders in patients with psoriatic arthritis and psoriasis Reumatologia 2018 56 301 30610.5114/reum.2018.79501626329830505012Search in Google Scholar

[81] Gupta M.A., Simpson F.C., Gupta A.K.: Psoriasis and sleep disorders: A systematic review. Sleep Med. Rev., 2016; 29: 63-75Gupta M.A. Simpson F.C. Gupta A.K. Psoriasis and sleep disorders: A systematic review Sleep Med. Rev 2016 29 63 7510.1016/j.smrv.2015.09.00326624228Search in Google Scholar

[82] Fortune D.G., Richards H.L., Kirby B., Bowcock S., Main C.J., Griffiths C.E.: A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br. J. Dermatol., 2002; 146: 458-465Fortune D.G. Richards H.L. Kirby B. Bowcock S. Main C.J. Griffiths C.E. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy Br. J. Dermatol 2002 146 458 46510.1046/j.1365-2133.2002.04622.x11952546Search in Google Scholar

[83] Piaserico S., Marinello E., Dessi A., Linder M.D., Coccarielli D., Peserico A.: Efficacy of biofeedback and cognitive-behavioural therapy in psoriatic patients: A single-blind, randomized and controlled study with added narrow-band ultraviolet B therapy. Acta Derm. Venereol., 2016; 96: 91-95Piaserico S. Marinello E. Dessi A. Linder M.D. Coccarielli D. Peserico A. Efficacy of biofeedback and cognitive-behavioural therapy in psoriatic patients: A single-blind, randomized and controlled study with added narrow-band ultraviolet B therapy Acta Derm. Venereol 2016 96 91 95Search in Google Scholar

[84] Tausk F., Whitmore S.E.: A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother. Psychosom., 1999; 68: 221-225Tausk F. Whitmore S.E. A pilot study of hypnosis in the treatment of patients with psoriasis Psychother. Psychosom 1999 68 221 22510.1159/00001233610396014Search in Google Scholar

[85] Gaston L., Crombez J.C., Joly J., Hodgins S., Dumont M.: Efficacy of imagery and meditation techniques in treating psoriasis. Imagin. Cogn. Pers., 1989; 8: 25-38Gaston L. Crombez J.C. Joly J. Hodgins S. Dumont M. Efficacy of imagery and meditation techniques in treating psoriasis Imagin. Cogn. Pers 1989 8 25 3810.2190/PQKE-CMAM-T4MT-QVBLSearch in Google Scholar

[86] Kabat-Zinn J., Wheeler E., Light T., Skillings A., Scharf M.J., Cropley T.G., Hosmer D., Bernhard J.D.: Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom. Med., 1998; 60: 625-632Kabat-Zinn J. Wheeler E. Light T. Skillings A. Scharf M.J. Cropley T.G. Hosmer D. Bernhard J.D. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA) Psychosom. Med 1998 60 625 63210.1097/00006842-199809000-000209773769Search in Google Scholar

[87] Lazaroff I., Shimshoni R.: Effects of medical resonance therapy music on patients with psoriasis and neurodermatitis - a pilot study. Integr. Physiol. Behav. Sci., 2000; 35: 189-198Lazaroff I. Shimshoni R. Effects of medical resonance therapy music on patients with psoriasis and neurodermatitis - a pilot study Integr. Physiol. Behav. Sci 2000 35 189 19810.1007/BF0268877911286371Search in Google Scholar

[88] Lavda A.C., Webb T.L., Thompson A.R.: A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions. Br. J. Dermatol., 2012; 167: 970-979Lavda A.C. Webb T.L. Thompson A.R. A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions Br. J. Dermatol 2012 167 970 97910.1111/j.1365-2133.2012.11183.x22924999Search in Google Scholar

[89] Moon H.S., Mizara A., McBride S.R.: Psoriasis and psycho-dermatology. Dermatol. Ther., 2013; 3: 117-130Moon H.S. Mizara A. McBride S.R. Psoriasis and psycho-dermatology Dermatol. Ther 2013 3 117 13010.1007/s13555-013-0031-0388930524318414Search in Google Scholar

[90] Riyaz N., Arakkal F.R.: Spa therapy in dermatology. Indian J. Dermatol. Venereol. Leprol., 2011; 77: 128-134Riyaz N. Arakkal F.R. Spa therapy in dermatology Indian J. Dermatol. Venereol. Leprol 2011 77 128 13410.4103/0378-6323.7745021393940Search in Google Scholar

[91] Harari M.: Climatoterapia de las enfermedades de la Piel en el Mar Muerto - una Actualización. An. Hidrol. Médica., 2012; 5: 3951Harari M. Climatoterapia de las enfermedades de la Piel en el Mar Muerto - una Actualización An. Hidrol. Médica 2012 5 395110.5209/rev_ANHM.2012.v5.n1.39168Search in Google Scholar

[92] Kazandjieva J., Grozdev I., Darlenski R., Tsankov N.: Climatotherapy of psoriasis. Clin. Dermatol., 2008; 26: 477-485Kazandjieva J. Grozdev I. Darlenski R. Tsankov N. Climatotherapy of psoriasis Clin. Dermatol 2008 26 477 48510.1016/j.clindermatol.2008.05.001Search in Google Scholar

[93] Hodak E., Gottlieb A.B., Segal T., Politi Y., Maron L., Sulkes J., David M.: Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: Combined effects on epidermal and immunologic activation. J. Am. Acad. Dermatol., 2003; 49: 451-457Hodak E. Gottlieb A.B. Segal T. Politi Y. Maron L. Sulkes J. David M. Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: Combined effects on epidermal and immunologic activation J. Am. Acad. Dermatol 2003 49 451 45710.1067/S0190-9622(03)00916-2Search in Google Scholar

[94] Péter I., Jagicza A., Ajtay Z., Boncz I., Kiss I., Szendi K., Kustán P., Németh B.: Balneotherapy in psoriasis rehabilitation. In Vivo, 2017; 31: 1163-1168Péter I. Jagicza A. Ajtay Z. Boncz I. Kiss I. Szendi K. Kustán P. Németh B. Balneotherapy in psoriasis rehabilitation In Vivo 2017 31 1163 1168Search in Google Scholar

[95] Abels D.J., Rose T., Bearman J.E.: Treatment of psoriasis at a Dead Sea dermatology clinic. Int. J. Dermatol., 1995; 34: 134-137Abels D.J. Rose T. Bearman J.E. Treatment of psoriasis at a Dead Sea dermatology clinic Int. J. Dermatol 1995 34 134 13710.1111/j.1365-4362.1995.tb03599.x7737775Search in Google Scholar

[96] Emmanuel T., Lybæk D., Johansen C., Iversen L.: Effect of Dead Sea climatotherapy on psoriasis; A prospective cohort study. Front. Med., 2020; 7: 83Emmanuel T. Lybæk D. Johansen C. Iversen L. Effect of Dead Sea climatotherapy on psoriasis; A prospective cohort study Front. Med 2020 7 8310.3389/fmed.2020.00083709337432258044Search in Google Scholar

[97] Shani J., Harari M., Hristakieva E., Seidl V., Bar-Giyora J.: Dead-Sea climatotherapy versus other modalities of treatment for psoriasis: Comparative cost-effectiveness. Int. J. Dermatol., 1999; 38: 252-262Shani J. Harari M. Hristakieva E. Seidl V. Bar-Giyora J. Dead-Sea climatotherapy versus other modalities of treatment for psoriasis: Comparative cost-effectiveness Int. J. Dermatol 1999 38 252 26210.1046/j.1365-4362.1999.00583.x10321939Search in Google Scholar

[98] Golušin Z., Jovanović M., Gajinov B.J., Jolić S.: Balneotherapy of psoriasis. Serbian J. Dermatol. Venereol., 2015; 6: 105-112Golušin Z. Jovanović M. Gajinov B.J. Jolić S. Balneotherapy of psoriasis Serbian J. Dermatol. Venereol 2015 6 105 11210.2478/sjdv-2014-0009Search in Google Scholar

[99] Soroka Y., Ma’or Z., Leshem Y., Verochovsky L., Neuman R., Brégégère F.M., Milner Y.: Aged keratinocyte phenotyping: Morphology, biochemical markers and effects of Dead Sea minerals. Exp. Gerontol., 2008; 43: 947-957Soroka Y. Ma’or Z. Leshem Y. Verochovsky L. Neuman R. Brégégère F.M. Milner Y. Aged keratinocyte phenotyping: Morphology, biochemical markers and effects of Dead Sea minerals Exp. Gerontol 2008 43 947 95710.1016/j.exger.2008.08.00318761079Search in Google Scholar

[100] Dawe R.S., Yule S., Cameron H., Moseley H., Ibbotson S.H., Ferguson J.: A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br. J. Dermatol., 2005; 153: 613-619Dawe R.S. Yule S. Cameron H. Moseley H. Ibbotson S.H. Ferguson J. A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br. J. Dermatol 2005 153 613 61910.1111/j.1365-2133.2005.06663.xSearch in Google Scholar

[101] Boros M., Kemény Á., Sebők B., Bagoly T., Perkecz A., Petőházi Z., Maász G., Schmidt J., Márk L., László T., et al.: Sulphurous medicinal waters increase somatostatin release: It is a possible mechanism of anti-inflammatory effect of balneotherapy in psoriasis. Eur. J. Integr. Med., 2013; 5: 109-118Boros M. Kemény Á. Sebők B. Bagoly T. Perkecz A. Petőházi Z. Maász G. Schmidt J. Márk L. László T. et al Sulphurous medicinal waters increase somatostatin release: It is a possible mechanism of anti-inflammatory effect of balneotherapy in psoriasis Eur. J. Integr. Med 2013 5 109 11810.1016/j.eujim.2012.09.005Search in Google Scholar

[102] Gálvez Galve J.J., Peiró P.S., Lucas M.O., Torres A.H., Gil E.S., Pérez M.B.: Quality of life and assessment after local application of sulphurous water in the home environment in patients with psoriasis vulgaris: A randomised placebo-controlled pilot study. Eur. J. Integr. Med., 2012; 4: e213-e218Gálvez Galve J.J. Peiró P.S. Lucas M.O. Torres A.H. Gil E.S. Pérez M.B. Quality of life and assessment after local application of sulphurous water in the home environment in patients with psoriasis vulgaris: A randomised placebo-controlled pilot study Eur. J. Integr. Med 2012 4 e213 e21810.1016/j.eujim.2012.01.001Search in Google Scholar

[103] Khalilzadeh S., Shirbeigi L., Naghizadeh A., Mehriardestani M., Shamohammadi S., Tabarrai M.: Use of mineral waters in the treatment of psoriasis: Perspectives of Persian and conventional medicine. Dermatol. Ther., 2019; 32: e12969Khalilzadeh S. Shirbeigi L. Naghizadeh A. Mehriardestani M. Shamohammadi S. Tabarrai M. Use of mineral waters in the treatment of psoriasis: Perspectives of Persian and conventional medicine Dermatol. Ther 2019 32 e1296910.1111/dth.1296931099439Search in Google Scholar

[104] Damevska K., França K., Lotti T., Nikolovska S., Pollozhani N.: Complementary and integrative therapies for psoriasis: Looking forward. Dermatol. Ther., 2018; 31: e12627Damevska K. França K. Lotti T. Nikolovska S. Pollozhani N. Complementary and integrative therapies for psoriasis: Looking forward Dermatol. Ther 2018 31 e1262710.1111/dth.12627Search in Google Scholar

[105] Melandri D., Albano V.M., Venturi M., Flamigni A., Vairetti M.: Efficacy of combined liman peloid baths and heliotherapy in the treatment of psoriasis at Cervia spa, Emilia, Italy. Int. J. Biometeorol., 2020; 64: 1145-1152Melandri D. Albano V.M. Venturi M. Flamigni A. Vairetti M. Efficacy of combined liman peloid baths and heliotherapy in the treatment of psoriasis at Cervia spa, Emilia, Italy Int. J. Biometeorol 2020 64 1145 115210.1007/s00484-020-01888-ySearch in Google Scholar

[106] Rokowska-Waluch A., Pielesiak A., Pawlaczyk M.: Spa-terapia w leczeniu łuszczycy. Przegl. Dermatol., 2009; 96: 367-370Rokowska-Waluch A. Pielesiak A. Pawlaczyk M. Spa-terapia w leczeniu łuszczycy Przegl. Dermatol 2009 96 367 370Search in Google Scholar

[107] Tsankov N.K.: High mountain climatotherapy. Clin. Dermatol., 1998; 16: 699-707Tsankov N.K. High mountain climatotherapy Clin. Dermatol 1998 16 699 70710.1016/S0738-081X(98)00071-6Search in Google Scholar